Moreover, enhanced Cdk5 immunoreactivity was observed in neurons undergoing early stage of NFTs degeneration and plaque-neurites in several regions of human AD brain (Pei et al., 1998). This evidence concerns the gene CDK5 and Alzheimer disease.